iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma

Show Description +

[No narration] Dr. Ibach demonstrates placement of the 1.8 x 0.5 mm biocompatible titanium implant iDose, which releases a proprietary formulation of travoprost inside the anterior chamber. An ab-interno approach is used to visualize the anterior chamber angle. The scleral anchor is then implanted into the trabecular meshwork, and secure attachment is ensured by nudging the device.

Posted: 6/15/2020

Keywords:

Drug Delivery

iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma

[No narration] Dr. Ibach demonstrates placement of the 1.8 x 0.5 mm biocompatible titanium implant iDose, which releases a proprietary formulation of travoprost inside the anterior chamber. An ab-interno approach is used to visualize the anterior chamber angle. The scleral anchor is then implanted into the trabecular meshwork, and secure attachment is ensured by nudging the device.

Posted: 6/15/2020

Keywords:

Drug Delivery

Please log in to leave a comment.

More in Glaucoma

Achieving Success in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

Collaborative Care in Interventional Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO

What Does It Mean to Be Interventional?

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Savak Teymoorian, MD, MBA; and Mitch Ibach, OD, FAAO